The prevalence of asthma is increasing due to increased exposure to infectious agents and other environmental factors that impact pathogenesis. To address this need, the 2023 Thomas L. Petty Aspen Lung Conference will integrate basic, translational, and clinical approaches to:

  1. Understand the developmental origins of asthma,
  2. Evaluate the role of cell biology in defining asthma endotypes,
  3. Elucidate the contribution of microbiome and immune mechanisms to asthma pathogenesis, 
  4. Integrate cell and molecular mechanisms in relationship to clinical complexity of asthma, and 
  5. Discuss the future of asthma therapeutics.

The conference will provide an international forum that brings together leading basic, translational, and clinical researchers and welcomes trainees across the fields of pulmonary medicine, genetics, cell biology and immunology with the goal of identifying shared interests that will lead to more productive research and ultimately, more effective and personalized therapies for asthma.

Finally, the varied scientific themes and therapeutic strategies that emerge during the conference will be reconciled in the Conference Summary presented by Dr. Sally Wenzel (University of Pittsburgh). Three Fellow Travel Awards will be awarded to fellows whose abstracts have been accepted for podium presentations.

 


 

We look forward to your participation in the Thomas L. Petty Aspen Lung Conference, 65th Annual Meeting and to a combination of outstanding science and great fun. We hope that you and your colleagues can join us.

Anthony N. Gerber, M.D., Ph.D., Chair
Monica Kraft, M.D., Co-Chair
Sunita Sharma, M.D., Co-Chair

 


 

Americans with Disabilities Act Statement: Please indicate if you have any need for auxiliary aids or special assistance services.